# Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization

> **NCT00630240** · — · COMPLETED · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 53 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00630240
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2009-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630240, "Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00630240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*